The safety and efficacy of vaborbactam in pediatric patients have been evaluated, but it is crucial to consider the child's age, weight, and overall health. Clinical trials have shown that meropenem-vaborbactam is generally well-tolerated in children, but as with any medication, it is essential to monitor for potential side effects, such as gastrointestinal discomfort, allergic reactions, and changes in liver enzyme levels.
